0,839  0,002  Dopamine D1 antagonist
0,815  0,003  5 Hydroxytryptamine release stimulant
0,697  0,004  5 Hydroxytryptamine release inhibitor
0,665  0,004  Alpha adrenoreceptor antagonist
0,646  0,003  Alpha 2 adrenoreceptor antagonist
0,649  0,012  Antiparkinsonian
0,636  0,003  LDLR expression enhancer
0,620  0,014  Vasodilator, peripheral
0,608  0,003  Alpha 2a adrenoreceptor antagonist
0,612  0,012  Spasmolytic
0,601  0,005  Muscle relaxant
0,599  0,004  Dopamine antagonist
0,598  0,003  Pneumotoxic
0,601  0,008  Cardiodepressant
0,588  0,019  Respiratory analeptic
0,566  0,005  Antiadrenergic
0,578  0,022  Aldehyde oxidase inhibitor
0,556  0,005  Adrenaline antagonist
0,554  0,005  Dopamine D2 antagonist
0,562  0,014  Cardiovascular analeptic
0,566  0,033  Analgesic
0,566  0,035  Antineoplastic (lung cancer)
0,530  0,008  Sedative
0,532  0,011  Tumour necrosis factor alpha release inhibitor
0,539  0,021  CYP2C19 substrate
0,522  0,005  Alpha 1 adrenoreceptor antagonist
0,522  0,022  CYP2D6 substrate
0,507  0,009  Sigma receptor agonist
0,492  0,005  Skeletal muscle relaxant
0,532  0,049  Caspase 9 stimulant
0,501  0,020  UGT1A9 substrate
0,504  0,025  Antipsychotic
0,506  0,043  Transcription factor NF kappa B inhibitor
0,466  0,004  Dopamine agonist
0,489  0,033  Histamine release inhibitor
0,481  0,030  Antidepressant
0,485  0,038  Antineoplastic (colorectal cancer)
0,451  0,005  Alpha 1a adrenoreceptor antagonist
0,477  0,037  Antineoplastic (colon cancer)
0,468  0,038  Prostate cancer treatment
0,446  0,017  Dependence treatment
0,463  0,037  Mood disorders treatment
0,451  0,028  Analeptic
0,478  0,059  Antineoplastic (breast cancer)
0,495  0,076  Apoptosis agonist
0,439  0,022  Hypoxia-inducible factor 1 alpha inhibitor
0,416  0,005  Cocaine dependence treatment
0,463  0,063  Alzheimer's disease treatment
0,449  0,049  Antipruritic, allergic
0,415  0,020  Psychostimulant
0,441  0,053  CYP3A4 substrate
0,421  0,034  Cardioprotectant
0,392  0,009  Tyrosine 3 hydroxylase inhibitor
0,381  0,004  Dopamine D5 antagonist
0,400  0,029  Free radical scavenger
0,404  0,034  Vasodilator, coronary
0,399  0,035  CYP2D6 inhibitor
0,376  0,013  UGT1A3 substrate
0,393  0,032  UGT2B4 substrate
0,396  0,046  Caspase 3 stimulant
0,359  0,016  UGT2B7 substrate
0,342  0,002  Factor III inhibitor
0,342  0,007  Alpha 2b adrenoreceptor antagonist
0,388  0,053  Antithrombotic
0,396  0,061  Ulceration
0,337  0,004  Alpha adrenoreceptor agonist
0,341  0,014  Cholinergic
0,340  0,012  5 Hydroxytryptamine 1E antagonist
0,364  0,037  Radiosensitizer
0,370  0,046  CYP1A2 substrate
0,373  0,051  Antineoplastic (ovarian cancer)
0,348  0,028  Antineoplastic enhancer
0,335  0,016  Antialcoholic
0,332  0,016  Tubulin antagonist
0,321  0,005  Alpha 2c adrenoreceptor antagonist
0,385  0,070  CYP2C19 inhibitor
0,358  0,044  Antioxidant
0,391  0,081  TNF expression inhibitor
0,336  0,025  UGT1A1 substrate
0,310  0,004  Alpha 1 adrenoreceptor agonist
0,347  0,044  Antineurogenic pain
0,307  0,007  Alpha 1b adrenoreceptor antagonist
0,308  0,020  Antineoplastic (squamous cell carcinoma)
0,295  0,009  5 Hydroxytryptamine 1A antagonist
0,325  0,040  Vasodilator
0,296  0,012  DNA intercalator
0,295  0,011  Topoisomerase I inhibitor
0,330  0,050  Antineoplastic (cervical cancer)
0,358  0,078  CYP2C9 substrate
0,296  0,017  Protein kinase stimulant
0,321  0,044  Superoxide dismutase inhibitor
0,320  0,043  Antineoplastic (liver cancer)
0,354  0,079  Antileukemic
0,351  0,078  Stroke treatment
0,314  0,040  Antimitotic
0,300  0,027  Antimigraine
0,303  0,032  Anesthetic general
0,269  0,004  Dopamine D2 agonist
0,304  0,043  5 Hydroxytryptamine uptake stimulant
0,266  0,006  Opioid kappa receptor antagonist
0,312  0,055  Huntington's disease treatment
0,300  0,044  UGT1A6 substrate
0,289  0,034  Antihypotensive
0,272  0,017  Acetylcholinesterase inhibitor
0,273  0,019  5 Hydroxytryptamine 2 antagonist
0,260  0,010  VEGF expression inhibitor
0,294  0,044  Antineoplastic (sarcoma)
0,272  0,023  Attention deficit/hyperactivity disorder treatment
0,320  0,072  Calcium channel activator
0,251  0,005  Antineoplastic alkaloid
0,256  0,012  UGT2B10 substrate
0,268  0,025  Tumour necrosis factor antagonist
0,298  0,057  NOS2 expression inhibitor
0,298  0,058  Antineoplastic (non-small cell lung cancer)
0,253  0,012  Expectorant
0,282  0,043  Antiarrhythmic
0,295  0,058  Cardiotonic
0,260  0,025  UGT2B15 substrate
0,254  0,018  5 Hydroxytryptamine 2B antagonist
0,311  0,076  Hepatic disorders treatment
0,258  0,025  Lipid peroxidase inhibitor
0,245  0,016  Antitussive
0,234  0,005  Prolactin inhibitor
0,358  0,133  Antineoplastic (solid tumors)
0,239  0,014  5 Hydroxytryptamine 1 antagonist
0,235  0,011  Antischistosomal
0,279  0,057  Acute neurologic disorders treatment
0,244  0,022  Toxic, respiratory center
0,229  0,009  Dopamine D3 antagonist
0,314  0,097  Cognition disorders treatment
0,240  0,023  UGT2B9 substrate
0,254  0,037  Antimutagenic
0,237  0,021  Neuropathy treatment
0,232  0,016  5 Hydroxytryptamine 2A antagonist
0,253  0,037  Male reproductive disfunction treatment
0,261  0,045  UDP-glucuronosyltransferase substrate
0,241  0,026  5 Hydroxytryptamine antagonist
0,253  0,040  P-glycoprotein inhibitor
0,233  0,020  Toll-Like receptor antagonist
0,271  0,062  Antiamyloidogenic
0,230  0,022  Uterine stimulant
0,228  0,024  Bipolar disorder treatment
0,222  0,018  Butyrylcholinesterase inhibitor
0,281  0,078  Antineoplastic (melanoma)
0,269  0,066  Hypoglycemic
0,216  0,014  UGT2B1 substrate
0,245  0,042  UGT1A4 substrate
0,268  0,068  Antineoplastic (glioma)
0,229  0,031  Acetylcholine M1 receptor antagonist
0,206  0,009  Alpha 1d adrenoreceptor antagonist
0,251  0,055  Antihypertriglyceridemic
0,249  0,058  Amyloid beta aggregation inhibitor
0,194  0,005  Alpha 2 adrenoreceptor agonist
0,263  0,074  DNA damaging
0,311  0,125  15-Lipoxygenase inhibitor
0,200  0,014  Opioid antagonist
0,281  0,096  Sodium/bile acid cotransporter inhibitor
0,212  0,028  Antifungal enhancer
0,217  0,037  Antiparkinsonian, tremor relieving
0,195  0,021  Movement disorders treatment
0,260  0,090  Antineoplastic (multiple myeloma)
0,223  0,054  Sleep disorders treatment
0,345  0,177  Antiinflammatory
0,255  0,089  Radioprotector
0,249  0,085  Chemoprotective
0,223  0,060  Nitric oxide antagonist
0,190  0,026  Autism spectrum disorders treatment
0,257  0,095  FMO3 substrate
0,234  0,072  Cyclic AMP phosphodiesterase inhibitor
0,172  0,012  Analgesic, opioid
0,169  0,010  Beta tubulin antagonist
0,162  0,005  Narcotic antagonist
0,236  0,080  Teratogen
0,260  0,110  AR expression inhibitor
0,187  0,039  NADPH oxidase inhibitor
0,250  0,103  Anxiolytic
0,172  0,026  Nav1.1 sodium channel blocker
0,176  0,030  Cyclooxygenase 3 inhibitor
0,199  0,053  Antineoplastic (gastric cancer)
0,161  0,017  5 Hydroxytryptamine 7 antagonist
0,154  0,012  Tocolytic
0,160  0,018  Acetylcholine nicotinic antagonist
0,194  0,053  Antipruritic
0,216  0,076  Antineoplastic (glioblastoma multiforme)
0,246  0,107  NOS3 expression inhibitor
0,155  0,016  Opioid mu receptor antagonist
0,262  0,123  Antineoplastic (small cell lung cancer)
0,249  0,111  CTGF expression inhibitor
0,187  0,049  Antineoplastic (carcinoma)
0,206  0,071  Neurotrophic factor enhancer
0,182  0,049  Interferon gamma antagonist
0,174  0,041  Cholinergic antagonist
0,217  0,085  Cytostatic
0,144  0,013  Tourette's syndrome treatment
0,171  0,040  Acetylcholine antagonist
0,158  0,027  Constipation treatment
0,172  0,041  Psychosexual dysfunction treatment
0,135  0,004  Sigma 2 receptor antagonist
0,153  0,023  Breast cancer-resistant protein inhibitor
0,157  0,029  Bronchodilator
0,139  0,011  Alpha tubulin antagonist
0,224  0,098  Proliferative diseases treatment
0,225  0,099  Interleukin agonist
0,166  0,042  Toll-Like receptor 2 antagonist
0,247  0,122  Interleukin 2 agonist
0,264  0,140  Antineoplastic (non-Hodgkin's lymphoma)
0,250  0,128  Apoptosis antagonist
0,246  0,125  Antiallergic
0,133  0,012  Sigma receptor antagonist
0,153  0,032  Antineoplastic (uterine cancer)
0,160  0,039  Antihelmintic (Trematoda)
0,193  0,073  CYP2B6 inhibitor
0,176  0,056  Diuretic
0,217  0,098  DNA synthesis inhibitor
0,122  0,003  Dopamine D1 agonist
0,225  0,109  Antineoplastic (pancreatic cancer)
0,138  0,021  UGT2B11 substrate
0,123  0,007  Opioid kappa receptor agonist
0,167  0,053  Erectile dysfunction treatment
0,200  0,088  VCAM1 expression inhibitor
0,231  0,121  12-Lipoxygenase inhibitor
0,239  0,129  Antineoplastic (osteosarcoma)
0,190  0,081  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,129  0,022  Adrenaline agonist
0,130  0,023  Opioid delta receptor antagonist
0,162  0,055  Hemostatic
0,147  0,041  Vanilloid 1 agonist
0,270  0,166  MAP kinase kinase 6 inhibitor
0,134  0,031  Toll-Like receptor 4 antagonist
0,114  0,011  Beta 3 adrenoreceptor antagonist
0,123  0,021  Dopamine D4 antagonist
0,116  0,015  Dopamine uptake inhibitor
0,127  0,026  5 Hydroxytryptamine agonist
0,105  0,004  Dopamine D5 agonist
0,112  0,014  5 Hydroxytryptamine 1A agonist
0,154  0,056  Adenylate cyclase stimulant
0,117  0,018  Neuronal nicotinic receptor antagonist
0,113  0,015  Glycine receptor agonist
0,151  0,053  Antiseptic
0,178  0,081  Hepatoprotectant
0,109  0,012  Opioid agonist
0,129  0,033  5 Hydroxytryptamine 2C antagonist
0,158  0,062  Genotoxic
0,115  0,020  mTOR complex 2 inhibitor
0,119  0,025  Restless leg syndrome treatment
0,099  0,005  Prolactin release inhibitor
0,190  0,096  Embryotoxic
0,117  0,023  Antiprotozoal activity enhancer
0,145  0,052  Topoisomerase II inhibitor
0,179  0,087  Cytotoxic
0,143  0,052  Antismoking
0,244  0,153  Immunosuppressant
0,099  0,010  Potassium channel (Ca-activated) blocker
0,156  0,067  Antiischemic, cerebral
0,102  0,016  Beta adrenoreceptor antagonist
0,128  0,042  Estrogen antagonist
0,138  0,052  Acetylcholine muscarinic antagonist
0,112  0,026  NMDA 2 receptor antagonist
0,225  0,142  CYP3A4 inhibitor
0,090  0,008  Potassium channel small-conductance Ca-activated blocker
0,255  0,173  Antibacterial
0,152  0,070  Antidiarrheal
0,148  0,067  SULT1A3 substrate
0,146  0,066  Amylase inhibitor
0,151  0,071  Antidote
0,158  0,079  Prostate disorders treatment
0,204  0,125  Flavin-containing monooxygenase substrate
0,182  0,103  Antiparkinsonian, rigidity relieving
0,185  0,107  Antineoplastic (lymphoma)
0,084  0,006  Alpha 1L adrenoreceptor antagonist
0,094  0,017  Uterine relaxant
0,129  0,052  Cystathionine beta-synthase inhibitor
0,186  0,109  Antiprotozoal (Leishmania)
0,126  0,051  SULT1A1 substrate
0,078  0,005  Vesicle monoamine transporter inhibitor
0,103  0,030  Glycine receptor antagonist
0,075  0,004  Guanylate cyclase inhibitor
0,220  0,150  GST M1-1 substrate
0,212  0,141  Metabolic disease treatment
0,112  0,042  Estrogen receptor beta antagonist
0,139  0,069  Neurotrophic factor
0,167  0,098  Non-steroidal antiinflammatory agent
0,086  0,016  Opioid mu receptor agonist
0,081  0,012  5 Hydroxytryptamine 7 agonist
0,102  0,033  Granulocyte macrophage colony stimulating factor agonist
0,169  0,100  Abortion inducer
0,100  0,032  Nicotinic alpha4beta2 receptor antagonist
0,153  0,085  Prostatic (benign) hyperplasia treatment
0,099  0,032  5 Hydroxytryptamine 1F antagonist
0,096  0,029  Estrogen receptor alpha antagonist
0,133  0,066  Alpha-N-acetylglucosaminidase inhibitor
0,108  0,042  NMDA receptor antagonist
0,105  0,042  Acetylcholine M3 receptor agonist
0,111  0,048  Creatine kinase inhibitor
0,108  0,047  mTOR complex 1 inhibitor
0,077  0,016  5 Hydroxytryptamine 2 agonist
0,081  0,020  NMDA 2B receptor antagonist
0,120  0,060  Microtubule formation inhibitor
0,202  0,143  Antihypoxic
0,082  0,024  NMDA 2C receptor antagonist
0,095  0,037  Phosphodiesterase 11A inhibitor
0,095  0,037  Phosphodiesterase XI inhibitor
0,221  0,164  FMO1 substrate
0,213  0,156  Antihypertensive
0,087  0,031  5 Hydroxytryptamine uptake inhibitor
0,121  0,065  Antiviral (Influenza B)
0,156  0,102  Succinate dehydrogenase inhibitor
0,180  0,126  Antineoplastic (renal cancer)
0,130  0,077  Toll-Like receptor 9 antagonist
0,146  0,094  Arachidonic acid antagonist
0,079  0,028  5 Hydroxytryptamine 2A agonist
0,111  0,060  Electron transport complex I inhibitor
0,126  0,076  Antihemorrhagic
0,057  0,007  Complement C5a chemotactic receptor antagonist
0,109  0,060  Mediator release inhibitor
0,089  0,040  CC chemokine 5 receptor agonist
0,111  0,063  Mucolytic
0,138  0,090  Chemopreventive
0,095  0,049  Phosphodiesterase IV inhibitor
0,108  0,061  DOPA decarboxylase inhibitor
0,082  0,037  HIV-1 integrase inhibitor
0,145  0,102  Antipruritic, non-allergic
0,063  0,020  Topoisomerase II beta inhibitor
0,074  0,031  Adrenaline uptake inhibitor
0,075  0,033  HIV-1 integrase (Strand Transfer) inhibitor
0,069  0,027  Beta 1 adrenoreceptor antagonist
0,225  0,183  Antineoplastic (endocrine cancer)
0,116  0,075  Antiprotozoal (Amoeba)
0,046  0,007  Nicotinic alpha3beta4 receptor agonist
0,062  0,024  Dopamine transporter inhibitor
0,135  0,096  Ca2+-transporting ATPase inhibitor
0,064  0,025  Nicotinic receptor alpha7 subunit antagonist
0,163  0,125  Antiglaucomic
0,051  0,014  Nociceptin (N/OFQ) receptor antagonist
0,095  0,057  Protein kinase C zeta inhibitor
0,069  0,032  5 Hydroxytryptamine 5A antagonist
0,125  0,089  Nav1.6 sodium channel blocker
0,042  0,007  Nociceptin (N/OFQ) receptor agonist
0,078  0,044  Histidine decarboxylase inhibitor
0,067  0,034  Acetylcholine M5 receptor antagonist
0,172  0,139  Antidiabetic symptomatic
0,110  0,078  Alkylator
0,092  0,060  SULT1E1 substrate
0,044  0,012  Melatonin agonist
0,143  0,113  Aldehyde oxidase substrate
0,075  0,044  Prokinetic
0,053  0,023  Phosphodiesterase 3B inhibitor
0,057  0,027  Beta 2 adrenoreceptor antagonist
0,043  0,014  Melatonin 2 agonist
0,032  0,004  NMDA receptor phencyclidine site antagonist
0,046  0,018  Phenylethanolamine N methyltransferase inhibitor
0,147  0,120  DNA methylase inhibitor
0,061  0,035  5 Hydroxytryptamine 5 antagonist
0,104  0,078  Acetylcholine release stimulant
0,090  0,065  HIV-1 integrase (Overall Integration) inhibitor
0,075  0,050  Glutamate decarboxylase inhibitor
0,087  0,063  Phosphodiesterase I inhibitor
0,099  0,075  Choleretic
0,135  0,111  Carcinogenic, group 1
0,111  0,087  Antifungal (Pneumocystis)
0,169  0,146  Age-related macular degeneration treatment
0,107  0,083  M18 aspartyl aminopeptidase inhibitor
0,057  0,034  5 Hydroxytryptamine 1 agonist
0,112  0,089  Anesthetic
0,074  0,052  Cushing's syndrome treatment
0,100  0,078  Multidrug resistance-associated protein 1 inhibitor
0,094  0,071  Sulfotransferase substrate
0,036  0,014  Sigma 1 receptor antagonist
0,129  0,107  Antinephritic
0,060  0,039  Bcl-xL inhibitor
0,060  0,038  Ryanodine receptor antagonist
0,028  0,008  Vesicular acetylcholine transporter inhibitor
0,131  0,112  Melanin inhibitor
0,142  0,124  Antiviral (Influenza)
0,180  0,162  Antiischemic
0,068  0,050  SULT2A1 substrate
0,040  0,024  5 Hydroxytryptamine 2B agonist
0,080  0,066  Estrogen-related receptor beta agonist
0,080  0,066  Insulin growth factor antagonist
0,169  0,155  Nitric-oxide synthase stimulant
0,044  0,032  5 Hydroxytryptamine 2C agonist
0,050  0,039  Glucose-6-phosphate translocase inhibitor
0,077  0,066  Calcium antagonist
0,107  0,097  Phosphodiesterase inhibitor
0,116  0,106  Antieczematic
0,015  0,005  Melatonin 2 antagonist
0,073  0,064  Histamine H1 receptor antagonist
0,060  0,052  Phosphodiesterase III inhibitor
0,082  0,074  Sodium/hydrogen exchanger 5 inhibitor
0,101  0,093  Myasthenia Gravis treatment
0,079  0,072  Vanilloid agonist
0,156  0,148  Antipyretic
0,212  0,205  Analgesic, non-opioid
0,098  0,091  Cholesterol synthesis inhibitor
0,135  0,129  Septic shock treatment
0,100  0,094  Menstruation disorders treatment
0,110  0,104  Skin whitener
0,073  0,069  MAP kinase kinase 7 inhibitor
0,107  0,105  Gastritis treatment
0,051  0,050  Postcoital contraceptive

